Antimicrobial stewardship is an organizational priority mandated by standards released from The Joint Commission and CMS to address growing concerns over antimicrobial resistance. With reimbursement and patient safety at stake, Sentri7 helps hospitals and health systems improve appropriate use of antibiotics, while arming clinicians with information to minimize drug costs, prevent harm, or avoid a potential medical situation.
Sentri7 helps hospitals quickly improve drug utilization and identify cost-saving opportunities to deliver tangible impacts on quality and expense. Care teams depend on Sentri7’s high-impact alerts to guide proper therapy, flag antimicrobial misuse, and identify opportunities to contain drug costs by proactively flagging drug substitutes.
Sentri7 supports the development of a robust antimicrobial stewardship program by ensuring regulatory compliance, reducing antimicrobial costs and improving patient care.
Sentri7 Rated Top Vendor to Drive Tangible Antimicrobial Stewardship Outcomes
-KLAS 2017 Antimicrobial Stewardship Report
Antimicrobial stewardship is only as successful as the program that supports a hospital’s efforts. Wolters Kluwer clinical experts help care teams develop robust programs based on a hospital’s current efforts and the actions required to align with the CDC core elements of an effective antimicrobial stewardship program. Learn more about Wolters Kluwer clinical services.
Clinicians have a powerful arsenal of capabilities to monitor and control antimicrobial use including:
See how United Regional Healthcare uses Sentri7 to support their antimicrobial stewardship program.
Know the relevant goals and timelines for the National Action Strategy for Combating Antibiotic-Resistant Bacteria
Understand regulations, guidelines, penalties and preparation to build your antimicrobial stewardship program